Company news

Novacyt SAS news in 2025

Novacyt SAS's news releases, calls and decks from 2025, newest first.

View company

Novacyt SA Expects Slight Increase In H2 2025 Revenues

October 22, 2025

ALNOV: EBITDA loss narrowed, cash remains strong, and reproductive health drives growth

September 30, 2025

REG - Novacyt S.A. - Notice of Results

September 18, 2025

REG - Novacyt S.A. - Appointment of Joint Corporate Broker

September 15, 2025

REG - Novacyt S.A. - Resolution re. Lab 21 HSE Prosecution

September 12, 2025

REG - Novacyt S.A. - Liquidity Agreement Monthly Update & TVR

August 1, 2025

Novacyt SA Expects H1 2025 Revenue To Be About £9.8 Mln

July 29, 2025

ALNOV: Liquidity contract activity increased share holdings to 104,002 and set a €5.00 buyback cap

July 28, 2025

REG - Novacyt S.A. - Launch of LightBench® Discover

July 15, 2025

Annual Report and Accounts for the year ended 2024

June 16, 2025

REG - Novacyt S.A. - Liquidity Agreement and Total Voting Rights

June 2, 2025

REG - Novacyt S.A. - AGM Voting

May 28, 2025

REG - Novacyt S.A. - Notice of AGM

May 12, 2025

2024 Full Year Results Presentation (EN)

May 1, 2025

ALNOV: GBP 8 million in savings and 26% growth in reproductive healthcare drive strong outlook

April 30, 2025

IVDR accreditation for Yourgene® QST*R Base assay

February 20, 2025

ALNOV: FY 2024 revenue up 85% to £19.6m, with strong Reproductive Health and cost efficiencies

January 30, 2025

Decks in 2025